151 related articles for article (PubMed ID: 33385371)
1. Palmitoylethanolamide (PEA) reduces postoperative adhesions after experimental strabismus surgery in rabbits by suppressing canonical and non-canonical TGFβ signaling through PPARα.
Li Y; Zhao S; Xu S; Li Y; Wang C; Ren J; Li F; Hu X; Lin K; Qiu Y; Xiu Y
Biochem Pharmacol; 2021 Feb; 184():114398. PubMed ID: 33385371
[TBL] [Abstract][Full Text] [Related]
2. NAAA inhibitor F96 attenuates BBB disruption and secondary injury after traumatic brain injury (TBI).
Li Y; Zhou P; Hu T; Ren J; Xu Y; Qiu Y; Lu C; Li Y
Eur J Pharmacol; 2021 Dec; 912():174561. PubMed ID: 34655598
[TBL] [Abstract][Full Text] [Related]
3. N-Acylethanolamine acid amidase (NAAA) inhibitor F215 as a novel therapeutic agent for osteoarthritis.
Zhou P; Xiang L; Yang Y; Wu Y; Hu T; Liu X; Lin F; Xiu Y; Wu K; Lu C; Ren J; Qiu Y; Li Y
Pharmacol Res; 2019 Jul; 145():104264. PubMed ID: 31063807
[TBL] [Abstract][Full Text] [Related]
4. Harnessing the anti-inflammatory potential of palmitoylethanolamide.
Alhouayek M; Muccioli GG
Drug Discov Today; 2014 Oct; 19(10):1632-9. PubMed ID: 24952959
[TBL] [Abstract][Full Text] [Related]
5. The Basal Pharmacology of Palmitoylethanolamide.
Rankin L; Fowler CJ
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114698
[TBL] [Abstract][Full Text] [Related]
6. Potential analgesic effects of a novel N-acylethanolamine acid amidase inhibitor F96 through PPAR-α.
Yang L; Li L; Chen L; Li Y; Chen H; Li Y; Ji G; Lin D; Liu Z; Qiu Y
Sci Rep; 2015 Aug; 5():13565. PubMed ID: 26310614
[TBL] [Abstract][Full Text] [Related]
7. Anti-Inflammatory Effects of Fucoxanthinol in LPS-Induced RAW264.7 Cells through the NAAA-PEA Pathway.
Jin W; Yang L; Yi Z; Fang H; Chen W; Hong Z; Zhang Y; Zhang G; Li L
Mar Drugs; 2020 Apr; 18(4):. PubMed ID: 32326173
[TBL] [Abstract][Full Text] [Related]
8. Activation and desensitization of TRPV1 channels in sensory neurons by the PPARα agonist palmitoylethanolamide.
Ambrosino P; Soldovieri MV; Russo C; Taglialatela M
Br J Pharmacol; 2013 Mar; 168(6):1430-44. PubMed ID: 23083124
[TBL] [Abstract][Full Text] [Related]
9. Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation.
Solorzano C; Zhu C; Battista N; Astarita G; Lodola A; Rivara S; Mor M; Russo R; Maccarrone M; Antonietti F; Duranti A; Tontini A; Cuzzocrea S; Tarzia G; Piomelli D
Proc Natl Acad Sci U S A; 2009 Dec; 106(49):20966-71. PubMed ID: 19926854
[TBL] [Abstract][Full Text] [Related]
10. Synergic Therapeutic Potential of PEA-Um Treatment and NAAA Enzyme Silencing In the Management of Neuroinflammation.
Casili G; Lanza M; Campolo M; Siracusa R; Paterniti I; Ardizzone A; Scuderi SA; Cuzzocrea S; Esposito E
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050589
[TBL] [Abstract][Full Text] [Related]
11. Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models.
Sasso O; Moreno-Sanz G; Martucci C; Realini N; Dionisi M; Mengatto L; Duranti A; Tarozzo G; Tarzia G; Mor M; Bertorelli R; Reggiani A; Piomelli D
Pain; 2013 Mar; 154(3):350-360. PubMed ID: 23218523
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor α mediates acute effects of palmitoylethanolamide on sensory neurons.
Khasabova IA; Xiong Y; Coicou LG; Piomelli D; Seybold V
J Neurosci; 2012 Sep; 32(37):12735-43. PubMed ID: 22972997
[TBL] [Abstract][Full Text] [Related]
13. The Nutraceutical N-Palmitoylethanolamide (PEA) Reveals Widespread Molecular Effects Unmasking New Therapeutic Targets in Murine Varicocele.
Antonuccio P; Marini HR; Micali A; Romeo C; Granese R; Retto A; Martino A; Benvenga S; Cuzzocrea S; Impellizzeri D; Di Paola R; Fusco R; Cervellione RM; Minutoli L
Nutrients; 2021 Feb; 13(3):. PubMed ID: 33668991
[TBL] [Abstract][Full Text] [Related]
14.
Piomelli D; Scalvini L; Fotio Y; Lodola A; Spadoni G; Tarzia G; Mor M
J Med Chem; 2020 Jul; 63(14):7475-7490. PubMed ID: 32191459
[No Abstract] [Full Text] [Related]
15. Palmitoylethanolamide reduces early renal dysfunction and injury caused by experimental ischemia and reperfusion in mice.
Di Paola R; Impellizzeri D; Mondello P; Velardi E; Aloisi C; Cappellani A; Esposito E; Cuzzocrea S
Shock; 2012 Oct; 38(4):356-66. PubMed ID: 22772472
[TBL] [Abstract][Full Text] [Related]
16. Palmitoylethanolamide counteracts hepatic metabolic inflexibility modulating mitochondrial function and efficiency in diet-induced obese mice.
Annunziata C; Lama A; Pirozzi C; Cavaliere G; Trinchese G; Di Guida F; Nitrato Izzo A; Cimmino F; Paciello O; De Biase D; Murru E; Banni S; Calignano A; Mollica MP; Mattace Raso G; Meli R
FASEB J; 2020 Jan; 34(1):350-364. PubMed ID: 31914699
[TBL] [Abstract][Full Text] [Related]
17. Palmitoylethanolamide and Its Biobehavioral Correlates in Autism Spectrum Disorder: A Systematic Review of Human and Animal Evidence.
Colizzi M; Bortoletto R; Costa R; Zoccante L
Nutrients; 2021 Apr; 13(4):. PubMed ID: 33919499
[TBL] [Abstract][Full Text] [Related]
18. N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis.
Alhouayek M; Bottemanne P; Subramanian KV; Lambert DM; Makriyannis A; Cani PD; Muccioli GG
FASEB J; 2015 Feb; 29(2):650-61. PubMed ID: 25384424
[TBL] [Abstract][Full Text] [Related]
19. N-acylethanolamine acid amidase (NAAA) inhibition decreases the motivation for alcohol in Marchigian Sardinian alcohol-preferring rats.
Fotio Y; Ciccocioppo R; Piomelli D
Psychopharmacology (Berl); 2021 Jan; 238(1):249-258. PubMed ID: 33037452
[TBL] [Abstract][Full Text] [Related]
20. PPARα-Dependent Effects of Palmitoylethanolamide Against Retinal Neovascularization and Fibrosis.
Ye S; Chen Q; Jiang N; Liang X; Li J; Zong R; Huang C; Qiu Y; Ma JX; Liu Z
Invest Ophthalmol Vis Sci; 2020 Apr; 61(4):15. PubMed ID: 32298438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
